Tesla Inc (TSLA) Expected to Announce Earnings of -$0.64 Per Share

Share on StockTwits

Brokerages forecast that Tesla Inc (NASDAQ:TSLA) will report ($0.64) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Six analysts have issued estimates for Tesla’s earnings. The lowest EPS estimate is ($1.53) and the highest is $0.19. Tesla reported earnings of ($3.06) per share during the same quarter last year, which would suggest a positive year over year growth rate of 79.1%. The firm is expected to issue its next quarterly earnings report on Wednesday, August 7th.

According to Zacks, analysts expect that Tesla will report full-year earnings of ($1.14) per share for the current financial year, with EPS estimates ranging from ($2.95) to $2.14. For the next fiscal year, analysts anticipate that the company will post earnings of $6.57 per share, with EPS estimates ranging from $1.25 to $14.14. Zacks’ EPS averages are an average based on a survey of sell-side research analysts that follow Tesla.

Tesla (NASDAQ:TSLA) last posted its quarterly earnings results on Wednesday, April 24th. The electric vehicle producer reported ($4.10) EPS for the quarter, missing the consensus estimate of ($2.51) by ($1.59). The firm had revenue of $4.54 billion during the quarter, compared to analyst estimates of $5.18 billion. Tesla had a negative net margin of 4.29% and a negative return on equity of 18.23%. The company’s revenue was up 33.2% on a year-over-year basis. During the same period last year, the company earned ($3.35) EPS.

A number of equities analysts have recently issued reports on the company. Evercore ISI dropped their target price on Tesla from $240.00 to $200.00 and set an “underperform” rating for the company in a report on Wednesday. They noted that the move was a valuation call. Barclays set a $192.00 target price on Tesla and gave the stock a “sell” rating in a report on Tuesday. BidaskClub raised Tesla from a “sell” rating to a “hold” rating in a report on Thursday, May 9th. Bank of America assumed coverage on Tesla in a report on Monday, May 6th. They issued an “underperform” rating and a $225.00 target price for the company. Finally, Royal Bank of Canada dropped their target price on Tesla from $200.00 to $190.00 and set an “underperform” rating for the company in a report on Monday, May 6th. Sixteen research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and eleven have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $303.47.

In other Tesla news, insider Jeffrey B. Straubel sold 15,000 shares of the stock in a transaction on Thursday, February 28th. The stock was sold at an average price of $316.95, for a total value of $4,754,250.00. Following the transaction, the insider now directly owns 321,398 shares in the company, valued at approximately $101,867,096.10. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Antonio J. Gracias sold 16,780 shares of the stock in a transaction on Wednesday, April 10th. The shares were sold at an average price of $275.92, for a total value of $4,629,937.60. Following the completion of the transaction, the director now owns 8,728 shares in the company, valued at $2,408,229.76. The disclosure for this sale can be found here. Insiders have sold a total of 78,560 shares of company stock valued at $21,772,906 over the last ninety days. Insiders own 22.80% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the business. Slow Capital Inc. boosted its position in shares of Tesla by 19.0% in the 1st quarter. Slow Capital Inc. now owns 7,775 shares of the electric vehicle producer’s stock worth $2,175,000 after purchasing an additional 1,241 shares during the last quarter. Kore Private Wealth LLC bought a new position in shares of Tesla in the 1st quarter worth $35,000. IHT Wealth Management LLC bought a new position in shares of Tesla in the 1st quarter worth $250,000. Financial Advocates Investment Management boosted its position in shares of Tesla by 11.6% in the 1st quarter. Financial Advocates Investment Management now owns 2,149 shares of the electric vehicle producer’s stock worth $602,000 after purchasing an additional 223 shares during the last quarter. Finally, Ferris Capital LLC boosted its position in shares of Tesla by 46.5% in the 1st quarter. Ferris Capital LLC now owns 315 shares of the electric vehicle producer’s stock worth $88,000 after purchasing an additional 100 shares during the last quarter. Hedge funds and other institutional investors own 59.71% of the company’s stock.

Tesla stock traded down $2.95 during trading hours on Friday, hitting $229.00. The stock had a trading volume of 348,054 shares, compared to its average volume of 9,328,599. Tesla has a fifty-two week low of $224.50 and a fifty-two week high of $387.46. The company has a quick ratio of 0.42, a current ratio of 0.83 and a debt-to-equity ratio of 1.79. The stock has a market cap of $39.44 billion, a price-to-earnings ratio of -39.98 and a beta of 0.27.

Tesla Company Profile

Tesla, Inc designs, develops, manufactures, and sells electric vehicles, and energy generation and storage systems in the United States, China, Netherlands, Norway, and internationally. The company operates in two segments, Automotive, and Energy Generation and Storage. The Automotive segment offers sedans and sport utility vehicles.

Further Reading: Institutional Investors

Get a free copy of the Zacks research report on Tesla (TSLA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Tesla (NASDAQ:TSLA)

Receive News & Ratings for Tesla Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tesla and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Atara Biotherapeutics  Now Covered by Stifel Nicolaus
Atara Biotherapeutics Now Covered by Stifel Nicolaus
Critical Contrast: MFC Bancorp  and Bancolombia
Critical Contrast: MFC Bancorp and Bancolombia
Paragon Banking Group’s  Hold Rating Reiterated at Numis Securities
Paragon Banking Group’s Hold Rating Reiterated at Numis Securities
Short Interest in Moleculin Biotech Inc  Grows By 327.4%
Short Interest in Moleculin Biotech Inc Grows By 327.4%
OrganiGram  Sets New 52-Week High at $11.30
OrganiGram Sets New 52-Week High at $11.30
Weekly Analysts’ Ratings Changes for Seres Therapeutics
Weekly Analysts’ Ratings Changes for Seres Therapeutics


© 2006-2019 Ticker Report